Results 151 to 160 of about 19,922 (207)

Long-Term Efficacy and Safety of Treatments for Chronic Peripheral Neuropathic Pain: A Systematic Review and Narrative Synthesis. [PDF]

Pain Ther
Eerdekens MH, Both C, Freitas RL.
europepmc   +1 more source

Long-term analgesic use after neuroma and upper limb nerve injury: patterns in Sweden. [PDF]

Pain Rep
Dahlin E, Perez R, Zimmerman M, Merlo J, Nyman E, Dahlin LB.   +5 more
europepmc   +1 more source

Current pharmacological and non-pharmacological approaches to chemotherapy-induced peripheral neuropathy and association with awareness of clinical guidelines. [PDF]

Jpn J Clin Oncol
Yamamoto S, Arao H, Nawata S, Nakashima T, Hanai A, Kogawa T, Yoshida Y.   +6 more
europepmc   +1 more source

Discovery of a potential novel pharmacogenomic biomarker on ANK3 gene for liafensine, a triple reuptake inhibitor for treatment-resistant depression. [PDF]

Transl Psychiatry
Luo W, Wang G, Whitaker JW, Dhali Z, Sun H, Lu H, Li X, Shi T, Zhang J.   +8 more
europepmc   +1 more source

Evaluating <i>Caenorhabditis elegans</i> as a Toxicity Model for Reuptake Inhibitors. [PDF]

MicroPubl Biol
Hernandez CE, Van Stone A, So C.
europepmc   +1 more source

Comparative effectiveness of antidepressants for depression using EHRs from two health systems. [PDF]

BMC Psychiatry
Hong H, Zhao C, Jeon K, Goicoechea EB, Brantner CL, Ringlein GV, Zandi PP, Gagliardi JP, Goes FS, Goldstein BA, Stuart EA.   +10 more
europepmc   +1 more source

Clinical effects of lamotrigine combined with duloxetine in the treatment of bipolar depression. [PDF]

BMC Pharmacol Toxicol
Wang X, Li S, Chen Y, Xu G, Jiang L, Rao J.   +5 more
europepmc   +1 more source

Duloxetine ameliorates acute pancreatitis-associated inflammation and modulates pain related neuroinflammatory pathways via modulation of SP-related neurokinin signaling and PAR2/TRPV1 pathways. [PDF]

Front Toxicol
Almutary KH, Elsheakh AR, Nader MA, Zaghloul MS.   +3 more
europepmc   +1 more source